| AA | Anaplastic Astrocytoma |
| AKT | Protein kinase B (pathway) |
| ALT | Alternative lengthening of telomeres |
| AML | Acute myeloid leukemia |
| ARX | Aristaless Related Homeobox protein/gene |
| ATM | Ataxia-telangiectasia (A-T) mutated protein |
| ATP | Adenosine triphosphate |
| ATRX | Alpha-thalassemia/mental retardation, X-linked protein |
| AURKA | Aurora Kinase A |
| BBB | Blood–brain barrier |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 gene/protein |
| CDK | Cyclin Dependent Kinase |
| CDKN2A | Cyclin Dependent Kinase Inhibitor 2A gene |
| CENP-A | Centromere protein A |
| Chk1 | Checkpoint kinase 1 |
| CNA | Copy number alteration |
| CNS | Central nervous system |
| DAXX | Death domain-associated protein |
| DDR | DNA damage response |
| DLX | Distal-less homeobox gene |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor protein |
| EOR | Extent of resection |
| ERK | Extracellular signal-regulated kinase (pathway) |
| FDA | U.S. Food and Drug Administration |
| FOXA1 | Forkhead Box A1 protein |
| FOXG1 | Forkhead box G1 protein |
| GAP | GTPase-activating protein |
| GDP | Guanosine 5′-diphosphate |
| GBM | Glioblastoma |
| GOF | Gain of function |
| GTP | Guanosine-5′-triphosphate |
| Gy | Gray, unit of ionizing radiation dose in the International System of Units (SI) |
| HDAC | Histone deacetylase |
| HIRA | Histone cell cycle regulator protein |
| HGG | High-grade glioma |
| HR | Homologous recombination |
| IDH1 | Isocitrate dehydrogenase 1 |
| KDM4 | Histone lysine demethylase 4 |
| LGG | Low-grade glioma |
| MAPK | Mitogen-activated protein kinase (pathway) |
| MDM | Mouse double minute homolog |
| MGMT | O-6-Methylguanine-DNA Methyltransferase |
| MOMP | Mitochondrial outer membrane permeabilization |
| MMR | Mismatch repair |
| MSI | Microsatellite instability |
| mTOR | Mammalian target of rapamycin pathway |
| MYCN | N-myc proto-oncogene protein |
| NBS | Non-brainstem |
| NF1 | Neurofibromin 1 protein/gene |
| NHEJ | Non-homologous end joining |
| NPC | Neural precursor cell |
| NSC | Neural stem cell |
| NSD | Nuclear receptor-binding SET domain protein |
| OLIG | Oligodendrocyte lineage gene |
| OPC | Oligodendrocyte precursor |
| PCR2 | Polycomb repressive complex 2 |
| PDGF | Platelet-derived growth factor |
| pHGG | Pediatric high-grade glioma |
| PI3K | Phosphoinositide 3-kinase (pathway) |
| PIP3 | Phosphatidylinositol (3,4,5)-trisphosphate |
| PLC/PKC | Phospholipase C/Protein kinase C pathway |
| Pol II | RNA Polymerase 2 |
| POU3F2 | POU class 3 homeobox 2 protein |
| PTEN | Phosphatase and tensin homolog |
| PTM | Posttranslational modification |
| PXA | Pleomorphic xanthoastrocytoma |
| Rb | Retinoblastoma (pathway) |
| RTK | Receptor tyrosine kinase |
| Sc-RNAseq | Single cell RNA sequencing |
| SETD2 | SET Domain Containing 2 protein |
| SVZ | Subventricular zone |
| TERT | Telomerase Reverse Transcriptase |
| TP53 | Tumor suppressor protein 53 (also P53) |
| Trk | Tropomyosin receptor kinase |
| UV | Ultraviolet |
| WAF1 | Cyclin-dependent kinase inhibitor 1 protein |
| WHO | World Health Organization |
| Wt | Wild type |